Hematology
Volume 26, 2021 - Issue 1
Open access
1,076
Views
1
CrossRef citations to date
0
Altmetric
Articles
Low dose of homoharringtonine and cytarabine-based priming induction regimens for patients with de novo acute myeloid leukemia and high-risk myelodysplastic syndrome aged over 70 years
Fang WangDepartment of Hematology/Oncology, First Hospital of Tsinghua University, Beijing, People’s Republic of ChinaView further author information
, Wenyan XuDepartment of Hematology/Oncology, First Hospital of Tsinghua University, Beijing, People’s Republic of ChinaView further author information
, Li LiuDepartment of Hematology/Oncology, First Hospital of Tsinghua University, Beijing, People’s Republic of ChinaView further author information
, Xiuhong RenDepartment of Hematology/Oncology, First Hospital of Tsinghua University, Beijing, People’s Republic of ChinaView further author information
, Pingping LiuDepartment of Hematology/Oncology, First Hospital of Tsinghua University, Beijing, People’s Republic of ChinaView further author information
, Li ZhengDepartment of Hematology/Oncology, First Hospital of Tsinghua University, Beijing, People’s Republic of ChinaView further author information
, Hao ZhangDepartment of Hematology/Oncology, First Hospital of Tsinghua University, Beijing, People’s Republic of ChinaView further author information
, Songsong ZhangDepartment of Hematology/Oncology, First Hospital of Tsinghua University, Beijing, People’s Republic of ChinaView further author information
, Yaru XuDepartment of Hematology/Oncology, First Hospital of Tsinghua University, Beijing, People’s Republic of ChinaView further author information
& Zhenxing GuoDepartment of Hematology/Oncology, First Hospital of Tsinghua University, Beijing, People’s Republic of ChinaCorrespondence[email protected]
View further author information
show allView further author information
Pages 1040-1045
|
Published online: 11 Dec 2021
Reprints and Permissions
This is an open access article distributed under the terms of the Creative Commons CC BY license, which permits unrestricted use, distribution, reproduction in any medium, provided the original work is properly cited.
You are not required to obtain permission to reuse this article in part or whole.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.